Estrogen Receptor (ESR1) mRNA Expression and Benefit From Tamoxifen in the Treatment and Prevention of Estrogen Receptor–Positive Breast Cancer

PURPOSE: Several mechanisms have been proposed to explain tamoxifen resistance of estrogen receptor (ER) –positive tumors, but a clinically useful explanation for such resistance has not been described. Because the ER is the treatment target for tamoxifen, a linear association between ER expression...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kim, Chungyeul, Tang, Gong, Pogue-Geile, Katherine L., Costantino, Joseph P., Baehner, Frederick L., Baker, Joffre, Cronin, Maureen T., Watson, Drew, Shak, Steven, Bohn, Olga L., Fumagalli, Debora, Taniyama, Yusuke, Lee, Ahwon, Reilly, Megan L., Vogel, Victor G., McCaskill-Stevens, Worta, Ford, Leslie G., Geyer, Charles E., Wickerham, D. Lawrence, Wolmark, Norman, Paik, Soonmyung
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2011
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3208536/
https://ncbi.nlm.nih.gov/pubmed/21947828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.9615
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires